Brookmont Capital Management recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
2000 MCKINNEY AVENUE DALLAS, TX 75201
As of the latest 13F report, the guru’s equity portfolio contained 47 stocks valued at a total of $163.00Mil. The top holdings were HD(31.83%), NVO(3.09%), and ABT(2.78%).
According to GuruFocus data, these were Brookmont Capital Management’s top five trades of the quarter.
Gilead Sciences Inc
During the quarter, Brookmont Capital Management bought 17,238 shares of NAS:GILD for a total holding of 46,580. The trade had a 0.91% impact on the equity portfolio. During the quarter, the stock traded for an average price of $79.19.
On 02/07/2023, Gilead Sciences Inc traded for a price of $86.36 per share and a market cap of $107.69Bil. The stock has returned 39.72% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Gilead Sciences Inc has a price-earnings ratio of 23.66, a price-book ratio of 5.11, a EV-to-Ebitda ratio of 15.29 and a price-sales ratio of 3.99.
The price-to-GF Value ratio is 1.19, earning the stock a GF Value rank of 3.
Eastman Chemical Co
Brookmont Capital Management reduced their investment in NYSE:EMN by 7,573 shares. The trade had a 0.37% impact on the equity portfolio. During the quarter, the stock traded for an average price of $80.56999999999999.
On 02/07/2023, Eastman Chemical Co traded for a price of $89.98999999999999 per share and a market cap of $10.69Bil. The stock has returned -21.94% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Eastman Chemical Co has a price-earnings ratio of 14.28, a price-book ratio of 2.01, a EV-to-Ebitda ratio of 9.33 and a price-sales ratio of 1.06.
The price-to-GF Value ratio is 0.77, earning the stock a GF Value rank of 10.
Shell PLC
During the quarter, Brookmont Capital Management bought 6,526 shares of NYSE:SHEL for a total holding of 70,485. The trade had a 0.23% impact on the equity portfolio. During the quarter, the stock traded for an average price of $55.12.
On 02/07/2023, Shell PLC traded for a price of $57.85 per share and a market cap of $201.17Bil. The stock has returned 7.71% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Shell PLC has a price-earnings ratio of 9.03, a price-book ratio of 1.07, a price-earnings-to-growth (PEG) ratio of 0.90, a EV-to-Ebitda ratio of 2.72 and a price-sales ratio of 0.57.
The price-to-GF Value ratio is 0.77, earning the stock a GF Value rank of 10.
Abbott Laboratories
During the quarter, Brookmont Capital Management bought 3,295 shares of NYSE:ABT for a total holding of 41,210. The trade had a 0.22% impact on the equity portfolio. During the quarter, the stock traded for an average price of $103.54.
On 02/07/2023, Abbott Laboratories traded for a price of $110.75 per share and a market cap of $193.10Bil. The stock has returned -13.14% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Abbott Laboratories has a price-earnings ratio of 28.32, a price-book ratio of 5.41, a price-earnings-to-growth (PEG) ratio of 1.30, a EV-to-Ebitda ratio of 17.01 and a price-sales ratio of 4.48.
The price-to-GF Value ratio is 0.85, earning the stock a GF Value rank of 9.
Chevron Corp
Brookmont Capital Management reduced their investment in NYSE:CVX by 2,219 shares. The trade had a 0.22% impact on the equity portfolio. During the quarter, the stock traded for an average price of $174.51.
On 02/07/2023, Chevron Corp traded for a price of $169.64 per share and a market cap of $328.02Bil. The stock has returned 29.03% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Chevron Corp has a price-earnings ratio of 9.28, a price-book ratio of 2.06, a price-earnings-to-growth (PEG) ratio of 1.03, a EV-to-Ebitda ratio of 5.03 and a price-sales ratio of 1.40.
The price-to-GF Value ratio is 0.88, earning the stock a GF Value rank of 7.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
